Methyl 4-bromo-5-fluoro-2-nitrobenzoate, 97.0%, 100g

2-Amino-4-(3-(benzyloxy)phenyl)-1H-pyrrole-3-carbonitrile, 95.0%, 1g

6-BROMO-2,3,4,5-TETRAHYDRO-1H-1-BENZAZEPINE, 95.0%, 1g

Fluorene>95.0%(GC)500g

3,6,9,12-Tetraoxatetradecane-1,14-diol, 1-4-methylbenzenesulfonate, 98%, 250mg

3-Chloro-2-hydroxypropanoic acid, 95.0%, 500mg

GC capillary column ROTI®Cap-1, 10 m, 0.53 mm, 1.00 µm, 1 Piece(s)

2-chloro-1-[2,5-dimethyl-1-(4H-1,2,4-triazol-3-yl)-1H-pyrrol-3-yl]ethan-1-one, 100mg

3-(4-bromophenyl)-6-chloropyridazine, 95.0%, 2g

D-Psicose>99.0%(HPLC)1g

2-((Benzylamino)methyl)phenol, 98%, 10g

n-(2-Amino-4-bromophenyl)acetamide, 97%, 250mg

{[(3-methylphenyl)methyl]sulfanyl}methanimidamide hydrobromide, 95.0%, 5g